{
    "Trade/Device Name(s)": [
        "i-STAT Hematocrit test with i-STAT Alinity System"
    ],
    "Submitter Information": "Abbott Point of Care Inc.",
    "510(k) Number": "K163342",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103195"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPI",
        "JGS"
    ],
    "Summary Letter Date": "July 24, 2017",
    "Summary Letter Received Date": "July 25, 2017",
    "Submission Date": "July 24, 2017",
    "Regulation Number(s)": [
        "21 CFR 864.6400",
        "21 CFR 862.1665"
    ],
    "Regulation Name(s)": [
        "Hematocrit measuring device",
        "Electrode, Ion Specific, Sodium"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hematocrit"
    ],
    "Specimen Type(s)": [
        "Arterial whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "Heparinized tube",
        "Non-anticoagulated collection (immediate use)"
    ],
    "Instrument(s)/Platform(s)": [
        "i-STAT Alinity System"
    ],
    "Method(s)/Technology(ies)": [
        "Conductivity method"
    ],
    "Methodologies": [
        "Quantitative in vitro measurement"
    ],
    "Submission Type(s)": [
        "Test",
        "Instrument",
        "System",
        "Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for i-STAT Hematocrit test with i-STAT Alinity System for quantitative hematocrit measurement using a handheld point-of-care analyzer.",
    "Indications for Use Summary": "For in vitro quantification of packed red blood cell volume fraction in arterial or venous heparinized or non-anticoagulated whole blood (not evaluated in neonates or with capillary samples); aids determination and monitoring of total red cell volume status associated with anemia and erythrocytosis.",
    "fda_folder": "Hematology"
}